comparemela.com
Home
Live Updates
Q32 Bio and Homology Medicines Announce Merger Agreement : comparemela.com
Q32 Bio and Homology Medicines Announce Merger Agreement
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart in Phase 2 for the treatment of atopic dermatitis and...
Related Keywords
Massachusetts ,
United States ,
Bedford ,
Waltham ,
Maria Marzilli ,
Saul Fink ,
Oxford Biomedica ,
Brendan Burns ,
Albert Seymour ,
David Appugliese ,
Shelia Violette ,
Piper Sandler ,
Jodie Morrison ,
Brad Smith ,
Sarah Sutton ,
Jason Campagna ,
Nasdaq ,
Exchange Commission ,
Corporate Strategy Program Operations ,
Bristol Myers Squibb ,
Oxford Biomedica Solutions ,
Homology Medicines Inc ,
Amgen ,
Latham Watkins ,
Bio Inc ,
Cu Healthcare Innovation Fund ,
Osage University Partners ,
Atlas Venture ,
Oxford Solutions ,
Goodwin Procter ,
Homology Medicines ,
Acorn Bioventures ,
Innovation Fund ,
Sanofi Ventures ,
Agent Capital ,
Chief Executive Officer ,
Associated Vasculitis ,
Homology Medicine ,
Current Report ,
Leerink Partners ,
Chief Executive ,
Chief Scientific ,
Chief Medical ,
Chief Technology ,
Executive Vice President ,
Corporate Strategy ,
Senior Vice President ,
Securities Litigation Reform Act ,
Homology Medicine Form ,
One Patriots Park ,
Markets ,
comparemela.com © 2020. All Rights Reserved.